The Clinical Features and Prognosis of Gastric Remnant Carcinoma after Treatment

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Symptoms</td><td align="center">Patients</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Epigastric pain/fullness</td><td align="center">9</td></tr><tr><td align="left"> Tarry stools/hematemesis</td><td align="center">5</td></tr><tr><td align="left">Poor appetite</td><td align="center">4</td></tr><tr><td align="left">Vomiting</td><td align="center">3</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Presenting symptoms of the 21 patients with gastric remnant carcinoma.

International Scholarly Research Notices

tab1

Table 1

Table 1: The Clinical Features and Prognosis of Gastric Remnant Carcinoma after Treatment 